Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123309444 | 12330944 | 4 | F | 2012 | 20160812 | 20160504 | 20160822 | PER | US-BAYER-2016-080502 | BAYER | 61.00 | YR | A | M | Y | 83.90000 | KG | 20160822 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123309444 | 12330944 | 1 | PS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | UNK | 19537 | TABLET | ||||||||||
| 123309444 | 12330944 | 2 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | 500 MG, BID | 19537 | 500 | MG | TABLET | BID | |||||||
| 123309444 | 12330944 | 3 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | 500 MG, BID | 19537 | 500 | MG | TABLET | BID | |||||||
| 123309444 | 12330944 | 4 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | 750 MG, BID | 19537 | 750 | MG | TABLET | BID | |||||||
| 123309444 | 12330944 | 5 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | UNK | 0 | |||||||||||
| 123309444 | 12330944 | 6 | C | IBUPROFEN. | IBUPROFEN | 1 | 800 MG, UNK | 0 | 800 | MG | |||||||||
| 123309444 | 12330944 | 7 | C | IBUPROFEN. | IBUPROFEN | 1 | 0 | ||||||||||||
| 123309444 | 12330944 | 8 | C | TAMSULOSIN | TAMSULOSIN | 1 | 0.4 MG, UNK | 0 | .4 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123309444 | 12330944 | 6 | Pain |
| 123309444 | 12330944 | 7 | Swelling |
| 123309444 | 12330944 | 8 | Prostatic disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123309444 | 12330944 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123309444 | 12330944 | Anxiety | |
| 123309444 | 12330944 | Balance disorder | |
| 123309444 | 12330944 | Cardiovascular disorder | |
| 123309444 | 12330944 | Hypoaesthesia | |
| 123309444 | 12330944 | Injury | |
| 123309444 | 12330944 | Limb discomfort | |
| 123309444 | 12330944 | Mental disorder | |
| 123309444 | 12330944 | Muscle atrophy | |
| 123309444 | 12330944 | Muscular weakness | |
| 123309444 | 12330944 | Musculoskeletal injury | |
| 123309444 | 12330944 | Nervous system disorder | |
| 123309444 | 12330944 | Neuropathy peripheral | |
| 123309444 | 12330944 | Peripheral swelling | |
| 123309444 | 12330944 | Peroneal nerve palsy | |
| 123309444 | 12330944 | Skin injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123309444 | 12330944 | 1 | 2009 | 0 | ||
| 123309444 | 12330944 | 2 | 20120516 | 20120526 | 0 | |
| 123309444 | 12330944 | 3 | 20131020 | 20131027 | 0 | |
| 123309444 | 12330944 | 4 | 20140510 | 20140510 | 0 | |
| 123309444 | 12330944 | 5 | 20120522 | 0 | ||
| 123309444 | 12330944 | 6 | 2010 | 0 |